StartupsYahoo Financeabout 8 hours ago
Parabilis Medicines Director Buys $474,000 in Stock
1 min read
Parabilis Medicines director Alan Sebulsky purchased 17,500 shares in open-market transactions on June 12 and June 15, 2026, for about $474,000. The weighted-average price of $27.06 per share was 8.2% above the June 15 close. All shares are held indirectly through Apothecary Capital LLC.
Level
Hype check
Tap to vote and see what everyone thinks.
